A certificate of analysis can report excellent results and still leave an important question unanswered: does it describe the material in your laboratory?
The connection between a vial, its supplier records and its analytical results is what makes batch traceability useful. Without that connection, a purity figure on a website tells you little about the particular delivery you received.
For laboratories buying research peptides, traceability also makes it easier to investigate unexpected results, compare repeat orders and identify which experiments used a particular lot. It does not guarantee that a peptide will perform as expected, but it gives researchers a documented starting point when something needs checking.
What is batch traceability?
Batch traceability means being able to follow an identified group of material through relevant production, supply and laboratory records.
In practical terms, a researcher should be able to start with a container or experimental record and work back to the supplier lot and its supporting documentation. Where a distributor assigns a different identifier, the records should explain the relationship.
This approach is already visible in established laboratory supply systems. Bachem’s analytical data sheet service uses product and lot identifiers to retrieve the appropriate document; its guidance shows where those identifiers appear on labels and purchasing paperwork.[1]
The number is therefore a reference to evidence. Printing one on a label is only the first step.
Product codes, lot numbers and report numbers are different
| Identifier | What it usually identifies | What to check |
|---|---|---|
| Product or catalogue code | A product listing or specification | Does it match the peptide and supplied form ordered? |
| Manufacturer’s batch or lot number | A defined group of manufactured material | Can its identity and analytical documentation be retrieved? |
| Supplier or repacking lot number | Material tracked within the supplier’s system | Is there a documented link to the original batch? |
| Laboratory sample or report number | A sample submission or analytical report | Which supplied batch does it represent? |
| Internal container or aliquot ID | Material tracked inside your laboratory | Can it be traced back to the received lot? |
Terminology varies between organisations. Ask what each identifier represents instead of assuming that every number on a document has the same purpose.
Why the same product name does not mean the same batch
Reordering an identical catalogue item does not necessarily mean receiving material from the same production run.
Bachem’s technical FAQ explains that peptide impurity profiles and peptide content can differ between batches even when synthesis and purification protocols remain unchanged.[2] That is a reason to examine the new lot’s documentation, rather than assume the previous certificate still applies.
It also explains why a headline purity specification is insufficient for comparing two deliveries. Chromatographic purity and net peptide content describe different properties. A sample can contain counterions and water that are not represented by the usual peptide purity figure.[3]
Our explanation of what 99% peptide purity actually means covers that distinction in more detail.
For procurement, the implication is straightforward: keep the product specification and the evidence for the supplied batch together.
A change in lot does not automatically mean poorer material. Equally, meeting the same advertised specification does not establish that two batches are interchangeable in every assay.
Three ways traceability helps laboratory work
1. It makes unexpected results easier to investigate
Suppose an assay changes after a repeat order arrives. Without lot records, the laboratory may not know whether it changed peptide batches at the same time.
With those records, the team can examine the timing, compare analytical documents and decide whether a controlled comparison is warranted. Other explanations—including instrument performance, preparation differences and changes elsewhere in the assay—still need consideration.
Traceability helps identify a variable. It does not establish the cause by itself.
2. It makes supplier queries more specific
“We had a problem with the peptide” is difficult to investigate.
A query that includes the product code, supplied lot, order reference, relevant report and affected experiment gives the supplier a much clearer starting point. The laboratory can ask about a defined delivery instead of exchanging generic product information.
3. It helps locate affected material
If a supplier corrects a certificate or raises a concern about a lot, the laboratory needs to identify remaining stock and the work in which it was used.
A searchable lot record can connect that notice to particular containers, preparations and experiments. The value comes from being able to follow those connections without reconstructing them from memory.
How to check the connection between a vial and its COA
Begin with the delivered label and the certificate of analysis, or COA.
Check the product identity, supplied form and batch information. If the report uses a laboratory sample code instead of the supplier’s lot number, request the record connecting them. An unexplained difference deserves clarification; it does not automatically prove that the report is false.
OECD guidance for GLP studies specifically describes checking that container and label information corresponds with the COA or other supporting information. It also calls for characterisation information for each batch when multiple batches are used in a study.[4] Those are requirements within that GLP context; they provide a useful reference point for research purchasing checks.
Then ask what was actually tested:
- Was the sample taken from bulk peptide material or from the finished supplied product?
- Which batch did the submitted sample represent?
- Does the report cover the supplied formulation?
- If several manufacturing or filling stages were involved, how are their records connected?
A report on starting material should not be treated as evidence of every property of a subsequently formulated product. Likewise, a batch report does not, by itself, establish that every individual container was tested.
For the analytical details, see our guide to reading a peptide certificate of analysis.
What if the peptide has been repacked or relabelled?
An additional supplier label can create another link in the record.
For example, a distributor may identify its stock differently from the original manufacturer. The purchasing question is whether the two identifiers can be reconciled through documented records, and whether the analytical evidence applies to the material being supplied.
A useful regulated example appears in ICH Q7, the GMP guidance for active pharmaceutical ingredients. Its distribution provisions describe retaining the original manufacturer’s identity, manufacturer’s batch number, transport and distribution records, and authentic certificates of analysis.[5]
Q7 addresses pharmaceutical ingredients within its stated scope. It should not be presented as a blanket legal requirement for every research peptide transaction. The practical lesson for buyers is that a change of packaging or commercial supplier should not erase the material’s history.
For a formulated or blended product, ask about the finished batch as well as any ingredient batches. An ingredient certificate and a finished-product certificate answer different questions.
A practical example: tracing an aliquot back to a delivery
Consider this fictional record:
| Record | Example entry |
|---|---|
| Product code | PEPTIDE-X |
| Supplier lot | LOT-2609-B |
| Analytical report | LAB-18472, documented as representing LOT-2609-B |
| Received container | INV-0068 |
| Laboratory preparation | PREP-014 |
| Aliquot used | PREP-014-A03 |
| Experiment | ASSAY-112 |
These identifiers are illustrative and do not describe a Coridion Sciences product or test result.
If ASSAY-112 produces an unexpected result, the researcher can identify the aliquot, its preparation, the original container and the supplied lot. The same records can help locate other experiments that used the preparation.
If the record stops at “Peptide X”, that investigation becomes much harder. If it stops at a batch number with no retrievable report, an important part of the evidence is still missing.
Keeping traceability after delivery
Supplier paperwork is only useful if the laboratory retains the connection as material moves into its own inventory.
OECD’s Good In Vitro Method Practices guidance recommends tracking reagent preparation information such as supplier, catalogue and relevant lot numbers, preparation and expiry dates, and the operator involved. It also addresses labelling and storage according to the manufacturer’s information.[6]
A practical laboratory workflow can build on that principle:
- Create a receipt record. Save the delivered label, order reference and relevant documents against an internal inventory entry.
- Reconcile discrepancies. Record the supplier’s explanation for an identifier mismatch before relying on the report.
- Keep the document received. Save the actual certificate and any later corrected versions, with their dates. A bookmark alone may not preserve the earlier document.
- Connect new containers to their source. When material is transferred or divided, make the parent container or lot retrievable from the new identifier.
- Connect experiments to inventory. Record the preparation or container used, rather than only the peptide name.
- Record the decision when a lot changes. Decide whether the application needs additional checks, and document what was accepted and why.
The appropriate system depends on the laboratory. A small project may use controlled records in a spreadsheet; a larger operation may use a laboratory information management system. What matters is whether the records reliably answer the questions researchers need to ask.
For new orders, combine these checks with our guide to what to check before buying research peptides online.
Questions to ask before placing a repeat order
For work where continuity matters, ask the supplier:
- Will this order come from the same lot as the previous delivery?
- Could the order contain more than one lot?
- Can you provide the documentation for the lot being dispatched?
- How will you communicate a change in formulation, specification or available test information?
- Who should receive a technical query about a particular batch?
Do not assume that the certificate currently displayed online is the certificate for stock already in your laboratory. Product certificate services can support searches using product and lot information; Fisher Scientific, for example, provides those search fields and directs customers to support when a certificate cannot be located.[7]
For broader supplier assessment, use our research peptide supplier checklist.
Frequently asked questions
Does a matching batch number prove a COA is authentic?
No. Matching identifiers establish consistency between records, but numbers can be copied. Where verification matters, use the issuing organisation’s established document service or independently confirmed contact details. Ask it to confirm the report and the sample identity it records.
Does a traceable batch guarantee reproducible results?
No. Traceability makes material history available for investigation. Reproducibility also depends on the experimental method, sample preparation, equipment and other relevant variables.
Does each vial need a different batch number?
A batch number normally identifies a group of material, so multiple vials may share it. A laboratory can assign separate container identifiers when it needs to distinguish how individual vials were handled or used.
Does batch documentation make a research peptide suitable for human use?
No. A traceable supply history does not establish safety or suitability for human administration. Bachem’s technical guidance explicitly distinguishes research-grade peptides from pharmaceutical materials and states that its research-grade peptides are not for use as drugs.[2] For the wider UK context, see our guide to peptide legality in the UK.
Make traceability part of the purchasing decision
When assessing Coridion Sciences research peptides, request the documentation relevant to the product and lot you intend to purchase, then retain it with your laboratory records.
The useful question is more specific than “Does it have a batch number?” Ask whether someone can take a container from your inventory and identify its source, supporting analytical evidence and the experiments in which it was used.
That is where batch traceability becomes valuable to research.
Sources
- Bachem — Analytical data sheet (ADS). Product and lot identifiers used to retrieve analytical documentation. Read the source.
- Bachem — FAQ: frequently asked questions. See “Do I have to expect batch-to-batch variability?” and “What is the difference between ‘research-grade’ and ‘GMP-API’?” Read the source.
- Bachem — Quality Control of Amino Acids & Peptides: A Guide. Distinguishes chromatographic purity, peptide content and batch variation. Read the source.
- OECD (2018) — Management, Characterisation and Use of Test Items used in GLP studies. Advisory Document No. 19; particularly paragraphs 24 and 39. Read the source.
- ICH Q7 / FDA (2016) — Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients. Section 17.2, traceability of distributed APIs and intermediates. Read the source.
- OECD (2018) — Guidance Document on Good In Vitro Method Practices (GIVIMP). Chapter 4, section 4.2, materials and reagents. Read the source.
- Fisher Scientific — Finding Product Certificates. Product and lot information in certificate searches. Read the source.
Sources checked on 9 October 2026. The numbered references support the associated factual statements. The inventory example and suggested purchasing workflow are editorial recommendations, not reported experimental findings.